RxDoctor Payments Data

Emily Reynolds, OD

Optometrist · Kent, OHNPI 1841728359

Payments from drug & device makers

$755in general payments, 2019–2025

Across 34 payments — averaging $22.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$172
  • Oyster Point Pharma, Inc.$120
  • Alcon$114
  • Amgen$77
  • Apellis Pharmaceuticals, Inc.$62
  • Bausch & Lomb Americas Inc.$58
  • plus $152 from 4 others

What the payments were for

  • Speaking & faculty fees$182%
  • Food & beverage$73798%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$755 in reported general payments places this provider in the 50th percentile of 1,995 optometrist providers in Ohio.

See all optometrist providers in Ohio

Medicare billing

Part B allowed, 2024
$74,387
Medicare patients
533
Services billed
801

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine30$39,445
LumiganBimatoprost36$25,066
Cyclosporine12$9,773
Travoprost15$3,399
Prednisolone Acetate87$3,235
Latanoprost216$2,706
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol16$2,224
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat106$1,350
Brimonidine Tartrate65$1,324
ErythromycinErythromycin Base65$1,033
ValacyclovirValacyclovir Hcl21$969
Timolol Maleate75$718
Dorzolamide Hcl23$363
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha33$331
Ofloxacin26$325

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRestasis, Lumigan$172$64,51166 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,995 optometrist providers in Ohio.

Other optometrist in Kent

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →